Skip to main content

Predictors of immunotherapeutic benefits in patients with advanced melanoma and other malignancies treated with immune checkpoint inhibitors utilizing ORIEN "real-world" data

Publication ,  Conference
Tarhini, AA; Tan, AC; Xie, M; El Naqa, I; Saghand, PG; Dai, D; Chen, JL; Ratan, A; McCarter, M; Carpten, JD; Colman, H; Ikeguchi, A; Hwu, P ...
Published in: JOURNAL OF CLINICAL ONCOLOGY
2022

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2022

Volume

40

Issue

16

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tarhini, A. A., Tan, A. C., Xie, M., El Naqa, I., Saghand, P. G., Dai, D., … Weiner, G. J. (2022). Predictors of immunotherapeutic benefits in patients with advanced melanoma and other malignancies treated with immune checkpoint inhibitors utilizing ORIEN "real-world" data. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40).
Tarhini, Ahmad A., Aik Choon Tan, Mengyu Xie, Issam El Naqa, Payman Ghasemi Saghand, Donghai Dai, James Lin Chen, et al. “Predictors of immunotherapeutic benefits in patients with advanced melanoma and other malignancies treated with immune checkpoint inhibitors utilizing ORIEN "real-world" data.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 40, 2022.
Tarhini AA, Tan AC, Xie M, El Naqa I, Saghand PG, Dai D, Chen JL, Ratan A, McCarter M, Carpten JD, Colman H, Ikeguchi A, Tripathi A, Puzanov I, Arnold SM, Churchman ML, Hwu P, Conejo-Garcia J, Dalton WS, Weiner GJ. Predictors of immunotherapeutic benefits in patients with advanced melanoma and other malignancies treated with immune checkpoint inhibitors utilizing ORIEN "real-world" data. JOURNAL OF CLINICAL ONCOLOGY. 2022.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2022

Volume

40

Issue

16

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences